These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1108508)

  • 21. [Candidiasis infection].
    Gschwind C
    Ther Umsch; 1985 Mar; 42(3):179-84. PubMed ID: 3887633
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mycotic vulvovaginitis].
    Margariti PA; Astorri AL; Mastromarino C; Morace G
    Recenti Prog Med; 1997 Oct; 88(10):479-84. PubMed ID: 9471643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Candidiasis of the urogenital system in women].
    Anton'ev AA; Mareeva FB
    Feldsher Akush; 1990 Jul; 55(7):21-8. PubMed ID: 2209862
    [No Abstract]   [Full Text] [Related]  

  • 25. [Genital candidiasis].
    Kiriushchenkov AP
    Feldsher Akush; 1990 Dec; 55(12):50-2. PubMed ID: 2090502
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cultural and serologic examination for saccharomycetic infection in pregnant women (author's transl)].
    Dame WR; Fegeler W
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):276-80. PubMed ID: 333800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between activity of hydrolases in fungi isolated from vagina of pregnant women and selected symptoms].
    Nowakowska D; Kurnatowska A; Wilczyński J
    Wiad Parazytol; 2002; 48(3):263-9. PubMed ID: 16888971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
    Abu-Elteen KH
    Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women.
    Verghese S; Padmaja P; Asha M; Elizabeth SJ; Anitha A; Kundavi KM; Jayanthi N; Varma T
    Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
    Lynch ME; Sobel JD
    J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India.
    Ahmad A; Khan AU
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):68-71. PubMed ID: 19261369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
    J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic and clinical characteristics of mycotic vaginitis caused by Candida glabrata (Torulopsis glabrata)].
    Pawlik B; Liber Z; Warzyńska R
    Med Dosw Mikrobiol; 1989; 41(3-4):206-14. PubMed ID: 2701236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis.
    Friese K; Neumann G; Siebert J
    Arch Gynecol Obstet; 2003 Aug; 268(3):194-7. PubMed ID: 12942250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida tropicalis vulvovaginitis.
    Horowitz BJ; Edelstein SW; Lippman L
    Obstet Gynecol; 1985 Aug; 66(2):229-32. PubMed ID: 3895072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction.
    Weissenbacher T; Witkin SS; Ledger WJ; Tolbert V; Gingelmaier A; Scholz C; Weissenbacher ER; Friese K; Mylonas I
    Arch Gynecol Obstet; 2009 Feb; 279(2):125-9. PubMed ID: 18506464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
    Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
    Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Candidiasis in pregnant women and the filterable forms of Candida].
    Iartseva LD; Topleninova KA; Egorenkova AN; Churanova ZI
    Vopr Okhr Materin Det; 1976 May; 21(5):75-8. PubMed ID: 800308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.